SCHEMBL30438886

SCHEMBL30438886

COc1ccc(CSc2cnnc(OC)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.53
MAOB P27338 3/20 0.50
MAOA P21397 2/20 0.49
DAO P14920 3/20 0.47
TSHR P16473 3/20 0.46
LMNA P02545 2/20 0.43
MMP13 P45452 1/20 0.43
FFAR1 O14842 1/20 0.43
USP2 O75604 1/20 0.42
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TP53 P04637 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25218124 1.00 APP (0.53) APPMAOBMAOADAOTSHR
SCHEMBL30991709 0.85 DAO (0.51) APPMAOBMAOADAOTSHR
SCHEMBL25219724 0.85 DAO (0.51) APPMAOBMAOADAOTSHR
SCHEMBL3228582 0.76 APP (0.82) APPMAOBMAOADAOTSHR
SCHEMBL31294328 0.75 APP (0.49) APPMAOBMAOADAOTSHR
SCHEMBL25216613 0.75 TSHR (0.45) APPMAOBMAOADAOTSHR
SCHEMBL25260084 0.75 APP (0.51) APPMAOBMAOADAOTSHR
SCHEMBL6829802 0.75 APP (0.51) APPMAOBMAOADAOTSHR
SCHEMBL30991727 0.75 TSHR (0.45) APPMAOBMAOADAOTSHR
SCHEMBL30991743 0.75 APP (0.51) APPMAOBMAOADAOTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436955-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS Lario Therapeutics Limited (GB) 2024-10-02 EP disclosed
CN-118317950-A Sulfonamide compounds for the treatment of neurological disorders 拉里奥治疗有限公司 2024-07-09 CN disclosed
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed